Transcript Document
Sentinel Node Biopsy : the
way forward
Hemant Singhal
MS FRCSEd FRCS(Gen) FRCSC
Consultant Surgeon
Northwick Park & St Marks Hospital
Senior Lecturer, Imperial College School Of Medicine
These PowerPoint presentations are free to download only for
academic purposes, with due acknowledgements to authors
and this website.
Introduction
Who should have it
When
How
Who will do it
What can we hope to achieve
HEMANT SINGHAL
MARCH 2005
Background
95% of patients who present with breast
cancer have apparently local disease.
Indirect features to suggest systemic
involvement
axillary lymph node metastasis
tumour size, grade
vascular or lymphatic invasion
Her2neu status or p53 etc
HEMANT SINGHAL
MARCH 2005
Preoperative evaluation of axilla
Clinical examination inaccurate, false negative rate of
39-45%
Mammography/ultrasound
sensitivity of 70%
CT
MRI
PET
Ultrasound guided FNAC
HEMANT SINGHAL
MARCH 2005
Rationale for axillary surgery
Status
Local control
Survival impact (B04) study
10 years 5-6% worse
There is no tumour size so small that one can
ignore the axilla
upto 20% for T1a
HEMANT SINGHAL
MARCH 2005
Issues with axillary clearance
Maybe of limited therapeutic value
80% of patients maybe LN negative
Short term drains, seroma
Lymphoedema
Sensory loss in area of ICB
affects the lifestyle of a third
HEMANT SINGHAL
MARCH 2005
Sentinel node concept
Ramon Cabanas
coined the term
lymphatic drainage in ca penis
Donald Morton: malignant melanoma
HEMANT SINGHAL
MARCH 2005
Sentinel node concept
First draining lymph node
reflects the status of the axilla
can be identified and sampled
HEMANT SINGHAL
MARCH 2005
SENTINEL NODE CONCEPT
sentinel node refers to the "node on watch.”
this node is the first node to receive cancer cells and
that if this node is positive, there may be other
positive nodes upstream.
The cancer cells don't "skip" and go to higher nodes.
If this node is negative, all the upstream nodes are
negative 99 out of 100 times
HEMANT SINGHAL
MARCH 2005
After a crime, you don't interrogate a
bunch of people who were two blocks
away; you focus on eye witnesses at
the scene of the crime."
—Marisa Weiss, M.D.
HEMANT SINGHAL
MARCH 2005
Collective experience
ACS study ~ 5000 patients
ALMANAC ~UK study
18 other sizeable studies
88% LN detection
98% accuracy
7 series with 100% results
HEMANT SINGHAL
MARCH 2005
Nuclear medicine aspects
Amount of radioactivity
dose of 0.1 mCi for same-day and 0.4
mCi for day-before injection
Preop scintigram
useful initially
know that there is a localised SNB
abnormal pattern - Rotters, IM,
breast
HEMANT SINGHAL
MARCH 2005
Site of injection
SLN identified by
intraparenchymal
subdermal
intradermal
subareolar
HEMANT SINGHAL
injections
MARCH 2005
HEMANT SINGHAL
MARCH 2005
Surgical aspects
Identify blue lymphatics
track hot node
intraop palpation for involved node
gross disease can block localisation
HEMANT SINGHAL
MARCH 2005
HEMANT SINGHAL
MARCH 2005
HEMANT SINGHAL
MARCH 2005
HEMANT SINGHAL
MARCH 2005
HEMANT SINGHAL
MARCH 2005
Inaccurate results
The scenario of a negative (non-cancerous) sentinel
node and positive (cancerous) additional nodes in a
patient can occur for several reasons, including:
The timing of the dye injections
The type of dye/tracers used
The presence of more than one sentinel node
The way in which the initial node was sectioned or
stained in the pathology lab
HEMANT SINGHAL
MARCH 2005
Poor candidates
palpable lymph nodes
Locally advanced breast cancer
multi-focal breast cancer
previous breast surgery (including
breast reduction)
previous radiation therapy to the breast
HEMANT SINGHAL
MARCH 2005
American College of Surgeons
recommends
at least 30 snb followed by complete
axillary node dissection,
with an 85% success rate in identifying
the sentinel lymph node(s)
and a 5% or lower false positive rate.
HEMANT SINGHAL
MARCH 2005
Tips & Tricks
Map with probe
3D mental map
Allow adequate time after blue dye inj
LN is invariably lower than you think
Persevere
HEMANT SINGHAL
MARCH 2005
Can we stop after negative SNB
Axillary relapse, most studies have
median FU that is too short
melanoma about 3-4%
expect 1% for breast
0.4% at median fu of 84 months
Singhal 1996, MSKCC
HEMANT SINGHAL
MARCH 2005
Should you go back after SNB+
39% have further involved nodes
this may be obvious at first op
intraoperative analysis
cytology
10% false negative
frozen section
HEMANT SINGHAL
MARCH 2005
Axillary evaluation
Breast lump considered malignant
Ultrasound of axilla
Normal lymph nodes
Abnormal lym nodes
Fine needle aspirate
Benign cells
Malignant cells
Axillary clearance
HEMANT SINGHAL
MARCH 2005
SENTINEL NODE BIOPSY
Benign cells
Normal scan
SENTINEL NODE BIOPSY
Intraoperative cytology
Benign
Malignant
No further intervention
Axillary clearance
HEMANT SINGHAL
MARCH 2005
The important question
"HOW MANY lymph nodes are
positive?"
not just "ARE lymph nodes positive?"
HEMANT SINGHAL
MARCH 2005